Loading
Latest filing published 14 Feb 2023 for Comera Life Sciences Holdings, Inc., €13k.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Edward Aloysius Sullivan Jr. on record concern Comera Life Sciences Holdings, Inc. In total, 2 filings cover trades dated 4 January 2023.
On the market, this insider has only ever bought: 1 purchase, €13k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.
The newest entry dates from 14 February 2023: an open-market purchase of €13k, in Comera Life Sciences Holdings, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations